Form 4 Tracker
Chad M Robins

Director, CEO and Chairman · 5 filings · Latest: Apr 6, 2026

Adaptive Biotechnologies Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ADPT
Chad M RobinsDirector, CEO and ChairmanApr 8, 2026
Sale
$15.1937,263$566.0K2,180,518
ADPT
Chad M RobinsDirector, CEO and ChairmanApr 6, 2026
Sale
$14.4183,332$1.2M2,217,781
ADPT
Chad RobinsApr 8, 2026
Proposed Sale
$14.8437,263$553.0K
ADPT
Chad RobinsApr 6, 2026
Proposed Sale
$14.0883,332$1.2M
ADPT
ROBINS CHAD MMar 11, 2026
Proposed Sale
$14.52470,167$6.8M
ADPT
Chad M RobinsDirector, CEO and ChairmanMar 11, 2026
Sale
$13.17470,167$6.2M2,301,113
ADPT
Chad M RobinsDirector, CEO and ChairmanMar 3, 2026
Sale
$15.5253,083$823.8K1,934,247
ADPT
Chad M RobinsDirector, CEO and ChairmanMar 2, 2026
Sale
$15.82289,024$4.6M1,987,330
ADPT
Chad M RobinsDirector, CEO and ChairmanFeb 27, 2026
Sale
$15.99182,891$2.9M2,276,354
ADPT
Chad RobinsMar 3, 2026
Proposed Sale
$16.0853,083$853.6K
ADPT
Chad RobinsMar 2, 2026
Proposed Sale
$16.12289,024$4.7M
ADPT
Chad RobinsFeb 27, 2026
Proposed Sale
$16.02182,891$2.9M
ADPT
Chad M RobinsDirector, CEO and ChairmanFeb 2, 2026
Sale
$18.44124,998$2.3M2,459,245
ADPT
Chad RobinsFeb 2, 2026
Proposed Sale
$18.39124,998$2.3M
ADPT
Chad RobinsJan 5, 2026
Proposed Sale
$16.17124,998$2.0M
ADPT
Chad RobinsDec 1, 2025
Proposed Sale
$18.84124,998$2.4M
ADPT
Chad RobinsNov 26, 2025
Proposed Sale
$19.7235,736$704.7K
ADPT
Chad RobinsNov 12, 2025
Proposed Sale
$14.501,876$27.2K
ADPT
Chad RobinsNov 11, 2025
Proposed Sale
$14.531,237$18.0K
ADPT
Chad RobinsNov 10, 2025
Proposed Sale
$14.7186,161$1.3M